UnitedHealth and its pharmacy benefit manager OptumRx are being sued by an independent pharmacy for allegedly strong-arming pharmacies into agreeing to “unconscionable” performance-based fees, ...

UnitedHealth Group remains a Buy despite new risks like TrumpRx disruption and regulatory pressure. Read here for an analysis ...

It's unclear how "TrumpRx," the president's plan to lower prescription drug prices, will work and when, or to what extent, ...

First large-scale pharmacy care services company to implement fully sustainable packaging for temperature-sensitive prescriptions, reducing environmental impact New packaging eliminates polystyrene, ...

OptumRx, the pharmacy benefit management unit of UnitedHealth Group, is looking for a chief commercial client officer to oversee the company's go-to-market strategy. Responsibilities for the role ...

UnitedHealth Group's pharmacy benefit manager OptumRx announced Monday that it will acquire Diplomat, a struggling specialty pharmacy and PBM headquartered in Flint, Mich. Diplomat provides specialty ...

OptumRx, UnitedHealth Group’s pharmacy benefit manager unit, reportedly sent a letter to pharmaceutical companies in December outlining several demands drugmakers must meet if they decide to lower ...

UnitedHealth Group’s pharmacy benefit management business, OptumRx, managed to earn revenues of around $14.3 billion in 1Q16, which represents a YoY (year-over-year) rise of about 72%. The strong rise ...

OptumRx has to repay the state $15 million in prescription-drug overcharges assessed to the Ohio Bureau of Workers’ Compensation (BWC) under an agreement announced today by Ohio Attorney General Dave ...

OptumRx, Optum’s pharmacy benefit management company, has agreed to pay $20 million to settle allegations it improperly filled certain opioid prescriptions, violating the Controlled Substances Act.

CHICAGO & WOONSOCKET, R.I.--(BUSINESS WIRE)--OptumRx and CVS Pharmacy are partnering to provide more convenient choices and lower costs for consumers and clients while improving health outcomes.

As many patients deferred care due to COVID-19, OptumRx saw its first-fill script volume decline by one-third in the beginning of the second quarter, executives said Tuesday. Script volume began to ...